AQURE, Software version 2.3.0 and 2.3.1 Product Usage: The AQURE system is intended to let allow the management of analytical devices and operator profiles. The user can associate patient data with test data. The system shows test results. The system receives data from connected devices at the point-of care or laboratory. It can send test results to the HIS/LIS. The system lets the user send commands to selected devices. The system uses data related to the performance of devices, to tell users of issues to be managed. The AQURE system is intended for professional use.
Published May 9, 2018 · Recall initiated: February 27, 2018
Summary
FDA records medical device Class II recall Z-1582-2018, published May 9, 2018 and initiated February 27, 2018. Recalling firm: Radiometer Medical ApS; Status: Terminated; Reported quantity: 2; Lot: Version 2.3.0 and 2.3.1. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
There is a potential problem relating to the AQURE System, versions 2.3.0 and 2.3.1, that may result in patient mix-up.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Radiometer Medical ApS
- Distributor
- US Nationwide Distribution in the states to Georgia and Wisconsin.
- Lot
- Version 2.3.0 and 2.3.1
- Risk classification
- Class II
- Area (FDA)
- device
- Country
- Denmark
Related recalls
- FDAThe ABL90 FLEX and ABL90 FLEX PLUS analyzers are intended for use by trained technologists, nurses, physiciansOctober 21, 2026
- FDAABL800 FLEX Model Numbers 393-800 and 393-801 The ABL800 FLEX analyzers are intended for: " In Vitro testingJuly 31, 2024
- FDAAQURE REF 933-599 Software Versions 2.5.2 2.5.3 2.5.4 2.6.0 2.6.1 The AQURE system is intended to let youApril 26, 2023
- FDARadiometer, REF:956-552, PIC050- Arterial Blood Sampler 1 X 2 mL, 80 IU electrolyte-balanced heparin. Not forMay 25, 2022
- FDABeijing Syntech Laser APOLLO JV+ Medical Platform surgical lasersMay 9, 2018
- FDAAnalyzer and Atellica IM 1600 Analyzer system for in vitro diagnostic testing of clinical specimens.May 9, 2018
Questions about this recall
Was AQURE, Software version 2.3.0 and 2.3.1 Product Usage: The AQURE system is intended to let allow the management of analytical devices and operator profiles. The user can associate patient data with test data. The system shows test results. The system receives data from connected devices at the point-of care or laboratory. It can send test results to the HIS/LIS. The system lets the user send commands to selected devices. The system uses data related to the performance of devices, to tell users of issues to be managed. The AQURE system is intended for professional use. recalled?
Yes. FDA published recall Z-1582-2018 on May 9, 2018. Reported hazard: There is a potential problem relating to the AQURE System, versions 2.3.0 and 2.3.1, that may result in patient mix-up.
What should I do if I have this product?
Voluntary: Firm initiated · Letter